Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov and CTIS registry records · Last verified 26 Sep 2026 · Editorial standards

At a glance

The Affiliated Hospital of Qingdao University is the lead sponsor of 31 current clinical trials in our China register. 14 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Clostridium butyricum, Clostridium butyricum , Live and Dexamethasone. The most-studied condition is Stomach Neoplasms.

ClinicalTrials.gov trials by status

Recruiting1445%
Not yet open1342%
Active, closed413%

Trials by phase

Not applicable1135%
Observational826%
Phase 1516%
Phase 4310%
Phase 313%
Phase 1/213%
Phase 213%
Phase EARLY_PHASE113%

Clinical trials sponsored by The Affiliated Hospital of Qingdao University

31 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
The Effect of Oral Clostridium Butyricum on the Recurrence After Colonoscopic Resection of Colorectal Adenoma NCT07167342 · ClinicalTrials.gov ↗ · Colorectal Adenoma, Probiotics Drug: Clostridium butyricum , Live	Phase 4	Recruiting	2026-05	China
Clinical Study on the Application of 18F-HER2 Affibody PET Imaging in HER2-Expressing Breast Cancer NCT06916637 · ClinicalTrials.gov ↗ · Breast Cancer, Breast Cancer, HER2-Expression	Observational	Recruiting	2025-04	China
Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma NCT06916624 · ClinicalTrials.gov ↗ · Renal Cell Carcinoma (RCC), Clear Cell Renal Cell Carcinoma (ccRCC)	Observational	Recruiting	2025-04	China
Rapamycin-Eluting Vertebral Stents In The Real-World Treatment of Symptomatic Intracranial Atherosclerotic Stenosis NCT07352852 · ClinicalTrials.gov ↗ · Intracranial Arterial Stenosis, Brain Diseases	Observational	Recruiting	2025-05	China
Clinical Study of 18F-Labeled FAPI-04 in PET Imaging of Breast Cancer NCT06916338 · ClinicalTrials.gov ↗ · Breast Cancer	Observational	Recruiting	2025-04	China
Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not NCT05871099 · ClinicalTrials.gov ↗ · Gastric Cancer	Phase 3	Recruiting	2022-11	China
Multimodal Imaging Assessment of Chronic Kidney Disease Patients at Different Stages From a Cardio-Renal Interaction Perspective NCT07107919 · ClinicalTrials.gov ↗ · Chronic Kidney Disease, Cardiac Magnetic Resonance, 18F-FAPI	Observational	Recruiting	2025-07	China
A Randomized Trial of Annular Repair With Discectomy Versus Discectomy Alone for Lumbar Disc Herniation NCT07250581 · ClinicalTrials.gov ↗ · Lumbar Intervertebral Disc Herniation	Not applicable	Recruiting	2025-08	China
Multimodal Imaging Assessment After Revascularization in Patients With Acute Myocardial Infarction NCT07130409 · ClinicalTrials.gov ↗ · Cardiac Magnetic Resonance Imaging, Acute Myocardial Infarction (AMI), PET / MR	Observational	Recruiting	2025-08	China
A Multicenter, RCT Study of the Clinical Efficacy of Robotic and Laparoscopic Gastrectomy in Neoadjuvant Gastric Cancer NCT06042998 · ClinicalTrials.gov ↗ · Gastric Cancer Stage II, Gastric Cancer Stage III	Not applicable	Recruiting	2023-07	China
SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas NCT06544720 · ClinicalTrials.gov ↗ · Human Papillomavirus Associated Carcinomas, Cervical Cancer, Head and Neck Cancers	Phase 1	Recruiting	2023-08	China
Study on Human Bioequivalence of Triprerelin Acetate for Injection NCT06683066 · ClinicalTrials.gov ↗ · Prostate Cancer (CRPC)	Phase 1	Recruiting	2024-12	China
Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01） NCT06647680 · ClinicalTrials.gov ↗ · Rectal Cancer Patients	Phase 2	Recruiting	2025-06	China
Real-Time Diagnosis of Eosinophilic Nasal Polyps Using High-Sensitivity Spectroscopy NCT07125586 · ClinicalTrials.gov ↗ · Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)	Not applicable	Recruiting	2025-08	China
Home-based Whole Course Multimodal Prehabilitation Based on 5G + Artificial Intelligence Mobile Health NCT07764523 · ClinicalTrials.gov ↗ · Gastric Cancer, Prehabilitation	Not applicable	Not yet open	2026-08	China
A Prospective, Multicenter Exploratory Clinical Study on Consolidation Therapy With Tislelizumab Combined With Nintedanib for Limited-stage Small Cell Lung Cancer NCT07485920 · ClinicalTrials.gov ↗ · Limited-stage Small Cell Lung Cancer (LS-SCLC)	Phase 4	Not yet open	2026-05	China
Family-Supervised Prehabilitation to Reduce Postoperative Complications After Neoadjuvant Chemotherapy in Gastric Cancer NCT07183358 · ClinicalTrials.gov ↗ · Stomach Neoplasms, Neoadjuvant Therapy	Not applicable	Not yet open	2025-09	China
TEAS Timing for Gastrectomy Recovery (TEAS-TIME Trial) NCT07714980 · ClinicalTrials.gov ↗ · Gastric Cancer (GC), Stomach Neoplasms	Not applicable	Not yet open	2026-07	China
The Intraoperative Technical Errors of Robotic vs. Laparoscopic Radical Right Hemiclectomy NCT07138859 · ClinicalTrials.gov ↗ · Colorectal Carcinoma (CRC), Right Hemicolectomy	Not applicable	Not yet open	2025-08	China
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy NCT07676266 · ClinicalTrials.gov ↗ · Multiple Sclerosis (MS), Myasthenia Gravis (MG), Neuromyelitis Optica Spectrum Disorder	Phase 1	Not yet open	2026-07	China
The Correlation Between Sodium Urate (MSU) Deposition and Coronary Atherosclerosis in Patients With Foot Gout NCT07784049 · ClinicalTrials.gov ↗ · Gout, Coronary Atheroma	Observational	Not yet open	2026-08	China
Study on the Safety and Efficacy of Intratympanic Injection of Small Extracellular Vesicles Derived From Mesenchymal Stem Cells in Severe and Profound Sudden Sensorineural Hearing Loss NCT07404709 · ClinicalTrials.gov ↗ · Sudden Hearing Loss, Extracellular Vesicles Drug: Dexamethasone	Phase 1/2	Not yet open	2026-02	China
A Single-center, Open, Randomized, Single-dose, Cross-over Bioequivalence Study to Evaluate the Effects of the Test Formulation Abalparatide Injection and the Reference Formulation Abalparatide Injection (Tymlos®) in Healthy Adult Subjects NCT06753864 · ClinicalTrials.gov ↗ · Osteoporosis	Phase 1	Not yet open	2025-01	China
Safety and Efficacy of Small Extracellular Vesicles Nebulizer in Patients With Allergic Rhinitis Complicated With Asthma NCT07453771 · ClinicalTrials.gov ↗ · Allergic Rhinitis, Asthma	Not applicable	Not yet open	2026-03	China
Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Breast Cancer NCT05505812 · ClinicalTrials.gov ↗ · Breast Cancer Drug: HS-IT101	Phase EARLY_PHASE1	Not yet open	2022-10	China
The Effects of Clostridium Butyricum on Adverse Events During Adjuvant Chemotherapy for Colorectal Cancer NCT07152886 · ClinicalTrials.gov ↗ · Colorectal Cancer, Chemotherapeutic Toxicity Drug: Clostridium butyricum	Phase 4	Not yet open	2025-10	China
Multimodal Prehabilitation for Tumor-Related Bowel Obstruction NCT07767760 · ClinicalTrials.gov ↗ · Malignant Tumor, Prehabilitation	Not applicable	Not yet open	2026-08	China
Effect of Intraperitoneal Drain Placement on Postoperative Outcomes Following Laparoscopic Appendectomy in Adult Patients With Perforated Appendicitis NCT06927765 · ClinicalTrials.gov ↗ · Perforated Appendicitis	Observational	Active, closed	2024-06	China
Carina™ Surgical Platform for Minimal Radical Gastrectomy NCT07113340 · ClinicalTrials.gov ↗ · Robotic Gastrectomy, Stomach Neoplasms	Not applicable	Active, closed	2025-05	China
Safety, Tolerability, and Pharmacokinetics of Multiple-Dose RFUS-949 in Healthy Chinese Participants NCT07676357 · ClinicalTrials.gov ↗ · Acute and Chronic Pain	Phase 1	Active, closed	2026-01	China
Multimodal Prehabilitation To Improve The Clinical Outcomes Of Frail Elderly Patients With Gastric Cancer NCT05352802 · ClinicalTrials.gov ↗ · Stomach Neoplasms, Frail Elderly	Not applicable	Active, closed	2022-09	China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in The Affiliated Hospital of Qingdao University trials

4 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Clostridium butyricum1 Clostridium butyricum , Live1 Dexamethasone1 HS-IT1011

Conditions in The Affiliated Hospital of Qingdao University trials

50 conditions

Stomach Neoplasms4 Breast Cancer3 Gastric Cancer2Prehabilitation2Colorectal Adenoma1Probiotics1Breast Cancer, HER2-Expression1Limited-stage Small Cell Lung Cancer (LS-SCLC)1Neoadjuvant Therapy1 Renal Cell Carcinoma (RCC)1Clear Cell Renal Cell Carcinoma (ccRCC)1Perforated Appendicitis1Gastric Cancer (GC)1Colorectal Carcinoma (CRC)1Right Hemicolectomy1Intracranial Arterial Stenosis1Brain Diseases1Multiple Sclerosis (MS)1Myasthenia Gravis (MG)1Neuromyelitis Optica Spectrum Disorder1 Systemic Lupus Erythematosus1Gout1Coronary Atheroma1Chronic Kidney Disease1

By trial register

Register	Trials	Recruiting
Clinical trials in China	31	14

A trial with sites in more than one country appears in each of those registers.

Other sponsors in Stomach Neoplasms

Sponsor	Trials
SUNHO（China）BioPharmaceutical	1

Sponsors with the most current trials registered for this condition.

Questions about The Affiliated Hospital of Qingdao University trials

How many clinical trials does The Affiliated Hospital of Qingdao University sponsor?

The Affiliated Hospital of Qingdao University is the lead sponsor of 31 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are The Affiliated Hospital of Qingdao University trials recruiting?

Yes. 14 of its 31 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is The Affiliated Hospital of Qingdao University testing?

Its current trials name 4 drugs and biologicals as interventions. The most frequent are Clostridium butyricum (1), Clostridium butyricum , Live (1), Dexamethasone (1) and HS-IT101 (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.

The Affiliated Hospital of Qingdao University clinical trials